LIPOCINE INC. State and Local Income Tax Expense (Benefit), Continuing Operations
LIPOCINE INC. (LPCN) reported State and Local Income Tax Expense (Benefit), Continuing Operations of $200 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-03-10
- LIPOCINE INC. state and local income tax expense (benefit), continuing operations for fiscal 2025 was $200.00, a 70.63% decline from fiscal 2024.
- LIPOCINE INC. state and local income tax expense (benefit), continuing operations for fiscal 2024 was $681.00, a 9.80% decline from fiscal 2023.
- LIPOCINE INC. state and local income tax expense (benefit), continuing operations for fiscal 2023 was $755.00, a 10.87% increase from fiscal 2022.
- LIPOCINE INC. state and local income tax expense (benefit), continuing operations for fiscal 2022 was $681.00, a 240.50% increase from fiscal 2021.
| Period end | State and Local Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2025-12-31 | $200.00 10-K · filed 2026-03-10 |
| 2024-12-31 | $681.00 10-K · filed 2026-03-10 |
| 2023-12-31 | $755.00 10-K · filed 2025-03-13 |
| 2022-12-31 | $681.00 10-K · filed 2024-03-07 |
| 2021-12-31 | $200.00 10-K · filed 2023-03-10 |
| 2020-12-31 | $200.00 10-K · filed 2022-03-09 |
| 2019-12-31 | $200.00 10-K · filed 2021-03-11 |
| 2018-12-31 | $700.00 10-K · filed 2020-03-13 |
| 2017-12-31 | $700.00 10-K · filed 2019-03-06 |
| 2016-12-31 | $752.00 10-K · filed 2019-03-06 |
| 2015-12-31 | $200.00 10-K · filed 2018-03-12 |
| 2014-12-31 | $200.00 10-K · filed 2017-03-06 |
| 2013-12-31 | $100.00 10-K · filed 2015-03-11 |
| 2012-12-31 | $100.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |